Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway.
J Clin Immunol. 2023 Aug;43(6):1229-1240. doi: 10.1007/s10875-023-01475-x. Epub 2023 Mar 30.
Triglycerides (TG) and their major transport lipoprotein in the circulation (VLDL) appear to be related to inflammation. Patients with common variable immunodeficiency (CVID) have inflammatory complications associated with gut microbial dysbiosis. We hypothesized that CVID patients have disturbed TG/VLDL profiles associated with these clinical characteristics.
We measured plasma concentrations of TGs, inflammatory markers, and lipopolysaccharide (LPS) in 95 CVID patients and 28 healthy controls. Additionally, in 40 CVID patients, we explored plasma lipoprotein profiling, fatty acid, gut microbial dysbiosis, and diet.
TG levels were increased in CVID patients as compared to healthy controls (1.36 ± 0.53 mmol/l versus 1.08 ± 0.56 [mean, SD], respectively, P = 0.008), particularly in the clinical subgroup "Complications," characterized by autoimmunity and organ-specific inflammation, compared to "Infection only" (1.41 mmol/l, 0.71[median, IQR] versus [1.02 mmol/l, 0.50], P = 0.021). Lipoprotein profile analyses showed increased levels of all sizes of VLDL particles in CVID patients compared to controls. TG levels correlated positively with CRP (rho = 0.256, P = 0.015), IL-6 (rho = 0.237, P = 0.021), IL-12 (rho = 0.265, P = 0.009), LPS (r = 0.654, P = 6.59 × 10), CVID-specific gut dysbiosis index (r = 0.315, P = 0.048), and inversely with a favorable fatty acid profile (docosahexaenoic acid [rho = - 0.369, P = 0.021] and linoleic acid [rho = - 0.375, P = 0.019]). TGs and VLDL lipids did not appear to be associated with diet and there were no differences in body mass index (BMI) between CVID patients and controls.
We found increased plasma levels of TGs and all sizes of VLDL particles, which were associated with systemic inflammation, LPS, and gut dysbiosis in CVID, but not diet or BMI.
甘油三酯(TG)及其在循环中的主要转运脂蛋白(VLDL)似乎与炎症有关。患有普通变异性免疫缺陷(CVID)的患者有与肠道微生物失调相关的炎症并发症。我们假设 CVID 患者存在与这些临床特征相关的 TG/VLDL 谱紊乱。
我们测量了 95 例 CVID 患者和 28 例健康对照者的血浆 TG 浓度、炎症标志物和内毒素(LPS)。此外,在 40 例 CVID 患者中,我们探讨了血浆脂蛋白谱、脂肪酸、肠道微生物失调和饮食。
与健康对照组相比,CVID 患者的 TG 水平升高(分别为 1.36 ± 0.53 mmol/L 和 1.08 ± 0.56 [均值,SD],P=0.008),特别是在以自身免疫和器官特异性炎症为特征的“并发症”临床亚组中,与“感染仅”相比(1.41 mmol/L,0.71[中位数,IQR]与[1.02 mmol/L,0.50],P=0.021)。脂蛋白谱分析显示,与对照组相比,CVID 患者所有大小的 VLDL 颗粒水平均升高。TG 水平与 CRP(rho=0.256,P=0.015)、IL-6(rho=0.237,P=0.021)、IL-12(rho=0.265,P=0.009)、LPS(r=0.654,P=6.59×10)、CVID 特异性肠道菌群失调指数(r=0.315,P=0.048)呈正相关,与有利的脂肪酸谱呈负相关(二十二碳六烯酸[rho=−0.369,P=0.021]和亚油酸[rho=−0.375,P=0.019])。TG 和 VLDL 脂质似乎与饮食无关,CVID 患者和对照组之间的体重指数(BMI)也没有差异。
我们发现 CVID 患者的血浆 TG 和所有大小的 VLDL 颗粒水平升高,这些与全身炎症、LPS 和肠道菌群失调有关,但与饮食或 BMI 无关。